Busulfan plus melphalan versus high-dose melphalan as conditioning regimens in autologous stem cell transplantation for newly diagnosed multiple myeloma

BACKGROUND: High-dose melphalan (HDMEL) represents the standard conditioning regimen before autologous stem cell transplant (ASCT) in multiple myeloma (MM), but recent updates have suggested combination of melphalan with bulsulfan (BUMEL) is also associated with favorable outcomes. We performed the...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Blood Res
Main Authors: Byun, Ja Min, Lee, Jayoun, Shin, Sang-Jin, Kang, Minjoo, Yoon, Sung-Soo, Koh, Youngil
פורמט: Artigo
שפה:Inglês
יצא לאור: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2018
נושאים:
Original Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6021568/
https://ncbi.nlm.nih.gov/pubmed/29963515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5045/br.2018.53.2.105
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים